Fri, March 25, 2022
Thu, March 24, 2022
Wed, March 23, 2022
Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022
Wed, March 16, 2022
Tue, March 15, 2022
Mon, March 14, 2022

Vamil Divan Maintained (CABA) at Strong Buy with Decreased Target to $20 on, Mar 18th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-20-on-mar-18th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Vamil Divan of Mizuho, Maintained "Cabaletta Bio, Inc." (CABA) at Strong Buy with Decreased Target from $22 to $20 on, Mar 18th, 2022.

Vamil has made no other calls on CABA in the last 4 months.



There are 2 other peers that have a rating on CABA. Out of the 2 peers that are also analyzing CABA, 0 agree with Vamil's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vamil


  • Michael Ulz of "Morgan Stanley" Maintained at Buy with Decreased Target to $15 on, Wednesday, December 15th, 2021
  • Derek Archila of "Wells Fargo" Initiated at Buy and Held Target at $17 on, Wednesday, December 8th, 2021

Publication Contributing Sources